1. FRI0136 THE EFFICACY AND SAFETY OF SIROLIMUS IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: A RANDOMIZED AND PARALLEL-CONTROLLED CLINICAL TRIAL. (June 2019) Authors: Wang, Jia; Zhang, Sheng-xiao; Hu, Fang Yuan; Zheng, Xiao-Juan; Cheng, Ting; Yu, Na-Na; Yang, Wen-Xian; Gao, Chong; Wen, Hong-Yan; Xiao-Feng, LI Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial. (3rd November 2019) Authors: Wen, Hong-Yan; Wang, Jia; Zhang, Sheng-Xiao; Luo, Jing; Zhao, Xiang-Cong; Zhang, Chen; Wang, Cai-Hong; Hu, Fang-Yuan; Zheng, Xiao-Juan; Cheng, Ting; Niu, Hong-Qing; Liu, Guang-Ying; Yang, Wen-Xian; Yu, Na-Na; Ru, Jin-Li; Chen, Qi-Xiang; Lu, Xue-Chun; He, Pei-Feng; Gao, Chong; Li, Xiao-Feng Other Names: Zhang Minggang Guest Editor. Journal: Journal of immunology research Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗